MariMed Q2 Revenue Stagnates YoY, Provides Revised Financial Guidance
MariMed, Inc. (OTCQX: MRMD) (CSE:MRMD) released its financial results for the second quarter ended June 30, 2022, revealing revenue of $33 million, an increase of 1% compared to $32.6 million in Q2 2021.
